Tilray Brands (NASDAQ: TLRY)
Tilray Brands Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Tilray Brands Company Info
Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.
News & Analysis
1 Major Reason Cannabis Stocks Surged This Week
President Trump's social media feed put the markets in a frenzy.
3 Best Marijuana Stocks to Buy in October
These three cannabis companies offer different ways to play an industry that's down by 80% from its peak, but showing signs of life.
Why Tilray Brands Soared Monday and Pulled Back Some on Tuesday
After a huge pop Monday on a CBD video posted by President Trump, profit taking hit the cannabis trade.
Is Tilray Brands Stock a Buy?
This $1.74 billion company quietly built one of America's largest craft beer platforms -- and the market still prices it like a dying pot stock.
Why Tilray Brands Stock Exploded Today
Will President Trump finally legalize marijuana? It sure looks like it.
The Costly Mistake Investors Are (Still) Making With Tilray Brands Stock
Tilray Brands has been skyrocketing after some promising cannabis-related news, even though it may not necessarily help its business.
Is Tilray Brands a Dirt Cheap Growth Stock or Just a Bad Buy?
The company's trajectory in recent years suggests one clear answer.
If You'd Invested $1,000 in Tilray Stock 5 Years Ago, Here's How Much You'd Have Today
Tilray and the rest of the cannabis industry have not delivered on the hype.
Valuation
Earnings Transcripts
Tilray (TLRY) Q4 2025 Earnings Call Transcript
None
Tilray Brands (TLRY) Q2 2025 Earnings Call Transcript
TLRY earnings call for the period ending December 31, 2024.
Tilray Brands (TLRY) Q1 2025 Earnings Call Transcript
TLRY earnings call for the period ending September 30, 2024.
Tilray Brands (TLRY) Q4 2024 Earnings Call Transcript
TLRY earnings call for the period ending June 30, 2024.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.